Baqi L, Payer J, Killinger Z, Susienkova K, Jackuliak P, Cierny D, Langer P
5th Clinic of Internal Medicine, Faculty Hospital Ruzinov, and Department of Statistics, Economics University, Bratislava, Slovakia.
Endocr Regul. 2010 Jan;44(1):9-15. doi: 10.4149/endo_2010_01_9.
Since the positive role of thyrotropin (TSH) in bone remodeling has been recently emphasized, this cross-section study is aimed to evaluate the association of bone status with the level of TSH and free thyroxine (FT4) in the cohort of postmenopausal women after long-term treatment of thyroid disorders and age matched controls.
Urinary calcium (dUCa) and serum level of TSH, FT4 and of bone turnover markers (BTMs) such as alkaline phosphatase (ALP), osteocalcin (OC), cross linked N-telopeptide of type 1 collagen (NTx) as well as lumbar spine L 1-4 (BMD-L) and femoral hip (BMD-F) mineral density were determined in 113 postmenopausal women consisting of 42 patients with Graves disease treated by carbimazole, 32 patients with thyroid cancer treated with L-thyroxine and 39 age matched women without any thyroid and osteological disorders. For statistical evaluation t-test, Pearson's correlation coefficient and linear multiple regression were used.
To compare the association of TSH versus FT4 with BMD and BTMs the pooled cohort of all 113 women was divided in two groups in terms of TSH level: 1. 34 women with low TSH (>or=0.50 mU/l); 2. 79 women with normal TSH (0.51-4.3 mU/l). In spite of significantly higher FT4 level, the Group 2 with normal TSH level had significantly higher BMD-L and BMD-F (p<0.001) and, in contrast, significantly lower urinary dUCa, ALP, OC (all at p<0.001) and NTx (p<0.01) as compared to the Group 1 with low TSH level. Linear multiple regression showed highly significant influence of TSH on BMD-L and BMD-F0 (p<0.001) independent of age, FT4 and body mass index, while that of FT4 was not significant. The strength of linear interrelation between all variables used was finally tested by Pearson's correlation coefficient (Table 3) which was highly positive for TSH with BMD-F and BMD-L, but highly negative for TSH with serum NTx, OC, ALP) and urinary calcium (dUCa). In contrast, no significant correlation was found between the level of FT4 and BMD.
Irrespectively of FT4 level, postmenopausal women with normal TSH level showed a favorable bone status as compared to these with low level of TSH which is consistent with the view that TSH itself possibly participates in playing a favorable role in influencing the bone mineral density in adult women.
鉴于最近已强调促甲状腺激素(TSH)在骨重塑中的积极作用,本横断面研究旨在评估长期治疗甲状腺疾病后的绝经后女性队列以及年龄匹配的对照组中骨状态与TSH和游离甲状腺素(FT4)水平之间的关联。
测定了113名绝经后女性的尿钙(dUCa)、TSH、FT4血清水平以及骨转换标志物(BTMs),如碱性磷酸酶(ALP)、骨钙素(OC)、1型胶原交联N端肽(NTx),以及腰椎L1-4(BMD-L)和股骨颈(BMD-F)的骨密度。这113名绝经后女性包括42名接受卡比马唑治疗的格雷夫斯病患者、32名接受左甲状腺素治疗的甲状腺癌患者以及39名无任何甲状腺和骨病的年龄匹配女性。采用t检验、Pearson相关系数和线性多元回归进行统计学评估。
为比较TSH与FT4与骨密度和骨转换标志物之间的关联,根据TSH水平将所有113名女性的汇总队列分为两组:1. 34名TSH水平低(≥0.50 mU/l)的女性;2. 79名TSH水平正常(0.51 - 4.3 mU/l)的女性。尽管FT4水平显著更高,但TSH水平正常的第2组的BMD-L和BMD-F显著更高(p<0.001),相反,与TSH水平低的第1组相比,其尿dUCa、ALP、OC(均p<0.001)和NTx(p<0.01)显著更低。线性多元回归显示,TSH对BMD-L和BMD-F有高度显著影响(p<0.001),独立于年龄、FT4和体重指数,而FT4的影响不显著。最后通过Pearson相关系数检验了所有使用变量之间线性关系的强度(表3),TSH与BMD-F和BMD-L呈高度正相关,但与血清NTx、OC)、ALP和尿钙(dUCa)呈高度负相关。相反,未发现FT4水平与骨密度之间存在显著相关性。
与TSH水平低的绝经后女性相比,无论FT4水平如何,TSH水平正常的绝经后女性显示出良好的骨状态,这与TSH本身可能在影响成年女性骨密度方面发挥有利作用的观点一致。